
February 7, 2018 Medical Communications, Research and Development NHS, biotech, drugs, flu season, pharma, pharmaceutical

February 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, biotech, drugs, pharma, pharmaceutical

February 6, 2018 Manufacturing and Production, Medical Communications, Research and Development England, HPV, UK, human papillomavirus, pharma, vaccination

February 6, 2018 Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical

February 5, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

February 5, 2018 Medical Communications, Sales and Marketing GPs, NHS, UK, health, pharma

February 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, Alzheimer's, Apotex, AstraZeneca, Brexit Health Alliance, CDC, Duchenne Muscular Dystrophy, EMA, Italy, Sanofi, amazon, brexit, santhera, top ten

February 2, 2018 Medical Communications, Sales and Marketing Array Biopharma, AstraZeneca, lawsuit, selemetinib

February 2, 2018 Medical Communications, Sales and Marketing Allergan, Avycaz, FDA, pharma, pneumonia

February 1, 2018 Medical Communications biotech, drugs, pharma, pharmaceutical, stroke

February 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Teva, Working Life

January 31, 2018 Medical Communications Brenda Fitzgerald, CDC, US, pharma

January 31, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical

January 31, 2018 Medical Communications, Research and Development NHS Digital, biotech, drugs, immigration, pharma, pharmaceutical

January 31, 2018 Medical Communications, Research and Development India, Pfizer, antimicrobial resistance, pharma